The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study

• Main Authors: Chun-Chi Yang (Author), Ya-Wen Tsai (Author), Su-Hung Wang (Author), Jheng-Yan Wu (Author), Ting-Hui Liu (Author), Wan-Hsuan Hsu (Author), Po-Yu Huang (Author), Min-Hsiang Chuang (Author), Ming-Jen Sheu (Author), Chih-Cheng Lai (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The effectiveness of the novel oral antiviral agents, nirmatrelvir plus ritonavir and molnupiravir, in treating COVID-19 in patients with nonalcoholic fatty liver disease is unclear.Objective: To assess the effectiveness of novel oral antiviral agents against COVID-19 among patients with...